189 related articles for article (PubMed ID: 35346102)
1. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer.
Amitani M; Oba T; Kiyosawa N; Morikawa H; Chino T; Soma A; Shimizu T; Ohno K; Ono M; Ito T; Kanai T; Maeno K; Ito KI
BMC Cancer; 2022 Mar; 22(1):327. PubMed ID: 35346102
[TBL] [Abstract][Full Text] [Related]
2. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
[TBL] [Abstract][Full Text] [Related]
3. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer.
Oba T; Maeno K; Takekoshi D; Ono M; Ito T; Kanai T; Ito KI
BMC Cancer; 2020 Feb; 20(1):160. PubMed ID: 32106833
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
Harada T; Tsuji T; Ueno J; Koishihara Y; Konishi N; Hijikata N; Ishikawa A; Kotani D; Kojima T; Fujiwara H; Fujita T
Ann Surg Oncol; 2022 Dec; 29(13):8131-8139. PubMed ID: 35978207
[TBL] [Abstract][Full Text] [Related]
6. Change in skeletal muscle index and its prognostic significance in patients who underwent successful conversion therapy for initially unresectable colorectal cancer: observational study.
Nozawa H; Emoto S; Murono K; Shuno Y; Kawai K; Sasaki K; Sonoda H; Ishii H; Iida Y; Yokoyama Y; Anzai H; Ishihara S
Therap Adv Gastroenterol; 2020; 13():1756284820971197. PubMed ID: 33240393
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
8. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
[TBL] [Abstract][Full Text] [Related]
9. Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients.
Kwon MR; Ko ES; Park MS; Jeong WK; Hwang NY; Kim JH; Lee JE; Kim SW; Yu JH; Han BK; Ko EY; Choi JS; Park KW
Korean J Radiol; 2022 Feb; 23(2):159-171. PubMed ID: 35029082
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
11. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer.
Fujihata S; Ogawa R; Nakaya S; Hayakawa S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
Esophagus; 2021 Apr; 18(2):258-266. PubMed ID: 32889673
[TBL] [Abstract][Full Text] [Related]
12. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
13. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
14. Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer.
Shimura M; Mizuma M; Motoi F; Kusaka A; Aoki S; Iseki M; Inoue K; Douchi D; Nakayama S; Miura T; Ishida M; Ohtsuka H; Nakagawa K; Morikawa T; Kamei T; Unno M
Pancreatology; 2023 Jan; 23(1):65-72. PubMed ID: 36473785
[TBL] [Abstract][Full Text] [Related]
15. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international study.
Lin JX; Tang YH; Zhou WX; Desiderio J; Parisi A; Xie JW; Wang JB; Cianchi F; Antonuzzo L; Borghi F; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Staderini F; Marano A; Peluso C; Li P; Zheng CH; Ma YB; Huang CM
Clin Nutr; 2021 Aug; 40(8):4980-4987. PubMed ID: 34364237
[TBL] [Abstract][Full Text] [Related]
16. Low Skeletal Muscle Mass before Salvage-Line Chemotherapy Is a Poor Prognostic Factor in Patients with Refractory Metastatic Colorectal Cancer.
Miyamoto Y; Hiyoshi Y; Akiyama T; Kiyozumi Y; Eto K; Yohei N; Iwagami S; Baba Y; Yoshida N; Baba H
Digestion; 2019; 99(1):79-85. PubMed ID: 30554226
[TBL] [Abstract][Full Text] [Related]
17. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer.
Park SE; Choi JH; Park JY; Kim BJ; Kim JG; Kim JW; Park JM; Chi KC; Hwang IG
Sci Rep; 2020 Oct; 10(1):17683. PubMed ID: 33077864
[TBL] [Abstract][Full Text] [Related]
18. Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy.
Regnier P; DE Luca V; Brunelle S; Sfumato P; Walz J; Rybikowski S; Maubon T; Branger N; Fakhfakh S; Durand M; Gravis G; Pignot G
Minerva Urol Nephrol; 2021 Apr; 73(2):215-224. PubMed ID: 32083413
[TBL] [Abstract][Full Text] [Related]
19. Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?
Jang MK; Park S; Park C; Doorenbos AZ; Go J; Kim S
Breast; 2022 Dec; 66():1-7. PubMed ID: 36063619
[TBL] [Abstract][Full Text] [Related]
20. Skeletal Muscle Loss During Neoadjuvant Chemotherapy Predicts the Incidence of Postoperative Infectious Complications in Esophageal Cancer Patients Undergoing Esophagectomy.
Higashizono K; Sato S; Nakatani E; Hawke P; Nagai E; Taki Y; Nishida M; Watanabe M; Oba N
Cancer Diagn Progn; 2023; 3(1):67-74. PubMed ID: 36632592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
